Press Room

DCAT Week 2022

Start
Monday, March 21, 2022 - 00:00
End
Thursday, March 24, 2022 - 00:00
Location: New York, United States
Hovione present at DCAT WEEK

Meet Hovione at DCAT Week

 

Whether you would like to reconnect face-to-face with our team or still prefer to meet online, you can count on Hovione’s expert support. 

Meet our team in NY

Schedule a meeting online

Together we can take your project to market faster.

Hovione is a specialist integrated CDMO offering services for drug substance, drug product intermediate and drug product for oral and inhaled solutions. 

When looking for a fully Integrated Solution Provider for Inhalation, Hovione offers Customized high-performance APIs, Particle Engineering and Formulation along with a full range of highly specialized, innovative Inhalation Devices. 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025